Evidence map›Paper›PMID 30012821›Full record

ArticleStroke2018

Perivascular Spaces Volume in Sporadic and Hereditary (Dutch-Type) Cerebral Amyloid Angiopathy.

Sergi Martinez-Ramirez, Sanneke van Rooden, Andreas Charidimou, Anna Maria van Opstal, Marieke Wermer, M Edip Gurol, Gisela Terwindt, Jeroen van der Grond, Steven M Greenberg, Mark van Buchem and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Stroke, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2022
    Pooled it
  2. Enlarged perivascular spaces and florbetapir uptake in patients with intracerebral hemorrhage.European journal of nuclear medicine and molecular imaging · 2019
    Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Sergi Martinez-RamirezFrom the Department of Neurology, J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston (S.M.-R., A.C., M.E.G., S.M.G., A.V.).
Sanneke van RoodenDepartment of Radiology (S.v.R., A.M.v.O., M.W., J.v.d.G., M.v.B.).
Andreas CharidimouFrom the Department of Neurology, J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston (S.M.-R., A.C., M.E.G., S.M.G., A.V.).
Anna Maria van OpstalDepartment of Radiology (S.v.R., A.M.v.O., M.W., J.v.d.G., M.v.B.).
Marieke WermerDepartment of Radiology (S.v.R., A.M.v.O., M.W., J.v.d.G., M.v.B.).
M Edip GurolFrom the Department of Neurology, J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston (S.M.-R., A.C., M.E.G., S.M.G., A.V.).
Gisela TerwindtDepartment of Neurology (G.T.), Leiden University Medical Center, the Netherlands.
Jeroen van der GrondDepartment of Radiology (S.v.R., A.M.v.O., M.W., J.v.d.G., M.v.B.).
Steven M GreenbergFrom the Department of Neurology, J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston (S.M.-R., A.C., M.E.G., S.M.G., A.V.).
Mark van BuchemDepartment of Radiology (S.v.R., A.M.v.O., M.W., J.v.d.G., M.v.B.).
Anand ViswanathanFrom the Department of Neurology, J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston (S.M.-R., A.C., M.E.G., S.M.G., A.V.).
Massachusetts General Hospital · US

Funding

THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1985 to 2018
$42.1M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Christine S Ritchie · 2019 to 2026
$36.5M
Vascular Dysfunction in Cerebral Amyloid AngiopathyR01AG026484 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI GREENBERG, STEVEN M · 2005 to 2019
$7.5M
Vascular Pathology in Early and Asymptomatic Cerebral Amyloid AngiopathyR01AG047975 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI VISWANATHAN, ANAND · 2014 to 2025
$7.5M
Early Detection of Cerebral Amyloid AngiopathyR01NS070834 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI GREENBERG, STEVEN M · 2010 to 2014
$2.3M
NIA NIH HHS P30 AG062421NIA NIH HHS P50 AG005134NIA NIH HHS R01 AG026484NIA NIH HHS R01 AG047975NINDS NIH HHS R01 NS070834
6 · The paper itself

Abstract

Background and Purpose- Magnetic resonance imaging visible perivascular spaces in the centrum semiovale (CSO-PVS) have been associated with cerebral amyloid angiopathy (CAA).We aimed to further confirm this link by evaluating CSO-PVS volume in pathologically-demonstrated sporadic and genetically-demonstrated hereditary forms of the disease. Methods- We studied a retrospective hospital-based cohort consisting of 63 individuals aged >55 having brain magnetic resonance imaging and pathological assessment of CAA (mean age, 73.6±8.5; 46% female), and a separate cohort consisting of 26 carriers, and 28 noncarriers of the hereditary cerebral hemorrhage with amyloidosis-Dutch type (mean age, 46.7±12.8; 61.1% female). CSO-PVS volume was quantified on a single magnetic resonance imaging slice using a computer-assisted segmentation method and expressed as the relative volume of the intracranial volume in that particular slice (CSO-PVS relative volume). We compared CSO-PVS relative volume (1) between subjects with and without the disease in both cohorts; (2) between non-CAA, CAA without hemorrhage, and CAA with hemorrhage cases in the sporadic CAA cohort. All variables reaching P<0.1 in bivariate analyses were entered in logistic regression models. Results- In both sporadic and Dutch cohorts, cases with CAA had significantly higher CSO-PVS relative volume than cases without (median [IQR]: 3.7% [2.5-5.3] versus 1.8% [1.2-2.4], P<0.0001; 3.8% [0.6-6.2] versus 0.7% [0.4-1.6], P=0.007; respectively). In linear regression models, sporadic CAA was associated with higher CSO-PVS relative volume ( P=0.008). In the sporadic CAA cohort, compared with non-CAA cases, CSO-PVS relative volume was higher in both CAA with hemorrhage and without hemorrhage (4.4% [2.6-6.1] and 3% [2.4-3.6] versus 1.8% [1.2-2.4], P<0.001 and P=0.005, respectively). Higher CSO-PVS relative volume was associated with CAA in regression models, both when hemorrhage was present (odds ratio, 2.63; [95% confidence interval, 1.33-5.18]; P=0.005) and absent (odds ratio, 4.55; [95% confidence interval, 0.98-21.04]; P=0.05). Conclusions- Increased CSO-PVS volume is a consistent magnetic resonance imaging marker of cerebrovascular amyloid deposition and a promising diagnostic tool for sporadic CAA without hemorrhagic manifestations.

Indexed as

AdultAgedAged, 80 and overCerebral Amyloid AngiopathyCohort StudiesGlymphatic SystemHumansMagnetic Resonance ImagingMiddle AgedNetherlandsRetrospective Studiescerebral amyloid angiopathycerebral hemorrhagedrainageneuroimagingwhite matter

Identifiers

PMID30012821
PMCPMC6202219
OpenAlexW2884903446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.